SANOFI (1SAN.MI) Fundamental Analysis & Valuation

BIT:1SAN • FR0000120578

76.25 EUR
-1.33 (-1.71%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This 1SAN.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall 1SAN gets a fundamental rating of 5 out of 10. We evaluated 1SAN against 54 industry peers in the Pharmaceuticals industry. Both the profitability and the financial health of 1SAN get a neutral evaluation. Nothing too spectacular is happening here. 1SAN has a correct valuation and a medium growth rate. Finally 1SAN also has an excellent dividend rating. These ratings could make 1SAN a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

6

1. 1SAN.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1SAN was profitable.
  • 1SAN had a positive operating cash flow in the past year.
  • 1SAN had positive earnings in each of the past 5 years.
  • 1SAN had a positive operating cash flow in each of the past 5 years.
1SAN.MI Yearly Net Income VS EBIT VS OCF VS FCF1SAN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • The Return On Assets of 1SAN (9.85%) is better than 72.22% of its industry peers.
  • 1SAN has a better Return On Equity (17.49%) than 62.96% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 13.76%, 1SAN is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • 1SAN had an Average Return On Invested Capital over the past 3 years of 7.41%. This is significantly below the industry average of 14.78%.
  • The 3 year average ROIC (7.41%) for 1SAN is below the current ROIC(13.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.85%
ROE 17.49%
ROIC 13.76%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
1SAN.MI Yearly ROA, ROE, ROIC1SAN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • 1SAN's Profit Margin of 17.71% is fine compared to the rest of the industry. 1SAN outperforms 74.07% of its industry peers.
  • 1SAN's Profit Margin has declined in the last couple of years.
  • 1SAN has a Operating Margin (23.28%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of 1SAN has grown nicely.
  • 1SAN has a Gross Margin (72.55%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of 1SAN has remained more or less at the same level.
Industry RankSector Rank
OM 23.28%
PM (TTM) 17.71%
GM 72.55%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
1SAN.MI Yearly Profit, Operating, Gross Margins1SAN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. 1SAN.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1SAN is creating some value.
  • Compared to 1 year ago, 1SAN has less shares outstanding
  • 1SAN has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for 1SAN is higher compared to a year ago.
1SAN.MI Yearly Shares Outstanding1SAN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
1SAN.MI Yearly Total Debt VS Total Assets1SAN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • The Debt to FCF ratio of 1SAN is 1.86, which is an excellent value as it means it would take 1SAN, only 1.86 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 1.86, 1SAN belongs to the best of the industry, outperforming 85.19% of the companies in the same industry.
  • 1SAN has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
  • 1SAN's Debt to Equity ratio of 0.22 is fine compared to the rest of the industry. 1SAN outperforms 70.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.86
Altman-Z N/A
ROIC/WACC1.79
WACC7.68%
1SAN.MI Yearly LT Debt VS Equity VS FCF1SAN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • 1SAN has a Current Ratio of 1.09. This is a normal value and indicates that 1SAN is financially healthy and should not expect problems in meeting its short term obligations.
  • 1SAN has a worse Current ratio (1.09) than 70.37% of its industry peers.
  • A Quick Ratio of 1.09 indicates that 1SAN should not have too much problems paying its short term obligations.
  • The Quick ratio of 1SAN (1.09) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
1SAN.MI Yearly Current Assets VS Current Liabilites1SAN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 1SAN.MI Growth Analysis

3.1 Past

  • 1SAN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.82%.
  • 1SAN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.58% yearly.
  • The Revenue has been growing slightly by 5.29% in the past year.
  • Measured over the past years, 1SAN shows a small growth in Revenue. The Revenue has been growing by 4.57% on average per year.
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.49% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 5.29% on average over the next years.
EPS Next Y8.41%
EPS Next 2Y6.95%
EPS Next 3Y8.43%
EPS Next 5Y8.49%
Revenue Next Year6.58%
Revenue Next 2Y6.19%
Revenue Next 3Y5.8%
Revenue Next 5Y5.29%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1SAN.MI Yearly Revenue VS Estimates1SAN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
1SAN.MI Yearly EPS VS Estimates1SAN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. 1SAN.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.75 indicates a reasonable valuation of 1SAN.
  • 88.89% of the companies in the same industry are more expensive than 1SAN, based on the Price/Earnings ratio.
  • 1SAN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.29.
  • 1SAN is valuated reasonably with a Price/Forward Earnings ratio of 8.99.
  • 90.74% of the companies in the same industry are more expensive than 1SAN, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.60, 1SAN is valued rather cheaply.
Industry RankSector Rank
PE 9.75
Fwd PE 8.99
1SAN.MI Price Earnings VS Forward Price Earnings1SAN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1SAN indicates a somewhat cheap valuation: 1SAN is cheaper than 72.22% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.87
EV/EBITDA N/A
1SAN.MI Per share data1SAN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of 1SAN may justify a higher PE ratio.
PEG (NY)1.16
PEG (5Y)1.75
EPS Next 2Y6.95%
EPS Next 3Y8.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. 1SAN.MI Dividend Analysis

5.1 Amount

  • 1SAN has a Yearly Dividend Yield of 5.30%, which is a nice return.
  • 1SAN's Dividend Yield is rather good when compared to the industry average which is at 1.91. 1SAN pays more dividend than 92.59% of the companies in the same industry.
  • 1SAN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 5.3%

5.2 History

  • The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2Y6.95%
EPS Next 3Y8.43%
1SAN.MI Yearly Income VS Free CF VS Dividend1SAN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

Find the best dividend stocksShow peers with best dividend

1SAN.MI Fundamentals: All Metrics, Ratios and Statistics

SANOFI

BIT:1SAN (3/6/2026, 7:00:00 PM)

76.25

-1.33 (-1.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.23%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap184.17B
Revenue(TTM)70.49B
Net Income(TTM)12.49B
Analysts76
Price Target98.32 (28.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.3%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.22%
Min EPS beat(2)4.58%
Max EPS beat(2)5.86%
EPS beat(4)3
Avg EPS beat(4)3.54%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)6
Avg EPS beat(8)4.07%
EPS beat(12)8
Avg EPS beat(12)3.12%
EPS beat(16)11
Avg EPS beat(16)3.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.69%
Min Revenue beat(2)-2.08%
Max Revenue beat(2)-1.3%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.08%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.93%
Revenue beat(16)7
Avg Revenue beat(16)14.42%
PT rev (1m)-2.09%
PT rev (3m)-8.65%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)5.74%
EPS NY rev (1m)0.29%
EPS NY rev (3m)-1.32%
Revenue NQ rev (1m)-0.6%
Revenue NQ rev (3m)-1.7%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 9.75
Fwd PE 8.99
P/S 2.61
P/FCF 16.87
P/OCF 16.87
P/B 2.58
P/tB 48.27
EV/EBITDA N/A
EPS(TTM)7.82
EY10.26%
EPS(NY)8.48
Fwd EY11.12%
FCF(TTM)4.52
FCFY5.93%
OCF(TTM)4.52
OCFY5.93%
SpS29.19
BVpS29.55
TBVpS1.58
PEG (NY)1.16
PEG (5Y)1.75
Graham Number72.11
Profitability
Industry RankSector Rank
ROA 9.85%
ROE 17.49%
ROCE 16.67%
ROIC 13.76%
ROICexc 14.92%
ROICexgc 58.3%
OM 23.28%
PM (TTM) 17.71%
GM 72.55%
FCFM 15.49%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.86
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 87.43%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z N/A
F-Score5
WACC7.68%
ROIC/WACC1.79
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
EPS Next Y8.41%
EPS Next 2Y6.95%
EPS Next 3Y8.43%
EPS Next 5Y8.49%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%
Revenue Next Year6.58%
Revenue Next 2Y6.19%
Revenue Next 3Y5.8%
Revenue Next 5Y5.29%
EBIT growth 1Y7.73%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.69%
EBIT Next 3Y14.49%
EBIT Next 5Y9.74%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI / 1SAN.MI FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to 1SAN.MI.


What is the valuation status of SANOFI (1SAN.MI) stock?

ChartMill assigns a valuation rating of 5 / 10 to SANOFI (1SAN.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for SANOFI?

SANOFI (1SAN.MI) has a profitability rating of 6 / 10.


How financially healthy is SANOFI?

The financial health rating of SANOFI (1SAN.MI) is 3 / 10.


What is the expected EPS growth for SANOFI (1SAN.MI) stock?

The Earnings per Share (EPS) of SANOFI (1SAN.MI) is expected to grow by 8.41% in the next year.